About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Thrombosis and Atherosclerosis Research Institute
›
top-articles
Thrombosis and Atherosclerosis Research Institute
112
(top 1%)
papers
7.8K
(top 1%)
citations
32
(top 1%)
h
-index
89
(top 1%)
g
-index
125
all documents
8.4K
doc citations
1.8K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Lancet, The
2014
3,942
2
Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH
Journal of Thrombosis and Haemostasis
2015
889
3
Thrombosis: a major contributor to the global disease burden
Journal of Thrombosis and Haemostasis
2014
343
4
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
Journal of Thrombosis and Haemostasis
2016
285
5
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
BMJ: British Medical Journal
2019
177
6
Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein Receptor Suppression Mediated in Part by Proprotein Convertase Subtilisin/Kexin Type 9
Journal of the American College of Cardiology
2012
114
7
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
Blood
2014
114
8
Global public awareness of venous thromboembolism
Journal of Thrombosis and Haemostasis
2015
106
9
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
Blood
2020
106
10
Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran
Circulation
2012
105
11
Oral Direct Factor Xa Inhibitors
Circulation Research
2012
92
12
Hemophilia A and B: molecular and clinical similarities and differences
Haematologica
2019
89
13
Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome
Circulation
2019
84
14
Rivaroxaban for treatment of suspected or confirmed heparin‐induced thrombocytopenia study
Journal of Thrombosis and Haemostasis
2016
74
15
Gender Parity in Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine
2017
69
16
Comprehensive Plasma Metabolomic Analyses of Atherosclerotic Progression Reveal Alterations in Glycerophospholipid and Sphingolipid Metabolism in Apolipoprotein E-deficient Mice
Scientific Reports
2016
68
17
Comparison of the source and prognostic utility of cfDNA in trauma and sepsis
Intensive Care Medicine Experimental
2019
66
18
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?
Journal of Thrombosis and Thrombolysis
2013
59
19
Factors that predict thrombosis in relatives of patients with venous thromboembolism
Blood
2014
59
20
Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants
Thrombosis and Haemostasis
2015
59
21
Human Resistin Stimulates Hepatic Overproduction of Atherogenic ApoB-Containing Lipoprotein Particles by Enhancing ApoB Stability and Impairing Intracellular Insulin Signaling
Circulation Research
2011
55
22
Fibrinolysis: strategies to enhance the treatment of acute ischemic stroke
Journal of Thrombosis and Haemostasis
2018
53
23
Metabolic Syndrome and Acute Hyperglycemia Are Associated With Endoplasmic Reticulum Stress in Human Mononuclear Cells
Obesity
2012
52
24
Hospitalized COVID-19 Patients and Venous Thromboembolism
Circulation
2020
50
25
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Journal of the American College of Cardiology
2020
50
26
Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE)
Thrombosis and Haemostasis
2016
46
27
Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study
Journal of Thrombosis and Haemostasis
2021
45
28
Histidine-rich glycoprotein binds DNA and RNA and attenuates their capacity to activate the intrinsic coagulation pathway
Thrombosis and Haemostasis
2016
42
29
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study
Journal of Thrombosis and Haemostasis
2019
42
30
GWAS and ExWAS of blood mitochondrial DNA copy number identifies 71 loci and highlights a potential causal role in dementia
ELife
2022
42
31
Batroxobin Binds Fibrin with Higher Affinity and Promotes Clot Expansion to a Greater Extent than Thrombin
Journal of Biological Chemistry
2013
38
32
New oral anticoagulants: which one should my patient use?
Hematology American Society of Hematology Education Program
2012
37
33
Oncostatin M and TLR-4 Ligand Synergize to Induce MCP-1, IL-6, and VEGF in Human Aortic Adventitial Fibroblasts and Smooth Muscle Cells
Mediators of Inflammation
2013
34
34
4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques
Atherosclerosis
2017
34
35
A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal
Journal of Thrombosis and Thrombolysis
2015
32
36
Clinical implications of incidental venous thromboembolism in cancer patients
European Respiratory Journal
2020
31
37
Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice
Atherosclerosis
2013
30
38
Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure
Thrombosis and Haemostasis
2016
30
39
Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease
Circulation Research
2019
29
40
Pharmacologic tools to reduce bleeding in surgery
Hematology American Society of Hematology Education Program
2012
27
41
Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial
Journal of Thrombosis and Haemostasis
2014
26
42
Pediatric superior vena cava syndrome: An evidence‐based systematic review of the literature
Pediatric Blood and Cancer
2018
26
43
Characterization of mice harboring a variant of EPCR with impaired ability to bind protein C: novel role of EPCR in hematopoiesis
Blood
2015
24
44
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
Research and Practice in Thrombosis and Haemostasis
2021
23
45
Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review
Thrombosis and Haemostasis
2020
22
46
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE
Thrombosis Research
2020
22
47
Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models
Thrombosis and Haemostasis
2014
21
48
Polygenic Risk Score for Low-Density Lipoprotein Cholesterol Is Associated With Risk of Ischemic Heart Disease and Enriches for Individuals With Familial Hypercholesterolemia
Circulation Genomic and Precision Medicine
2021
21
49
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation
Thrombosis and Haemostasis
2015
20
50
Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels
Blood Advances
2017
20
site/software ©
exaly
; All materials licenced under
CC by-SA
.